Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05166629 · ClinicalTrials.gov registry record · NA
Eatable Alphabet as a Nutrition Education Tool
A NA study, sponsored by Northwell Health.
- Active
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT05166629: Active NA study, sponsored by Northwell Health.
NCT05166629 is a NA study that is active but no longer recruiting, run by Northwell Health. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05166629, a NA study, is active but no longer recruiting, sponsored by Northwell Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This pilot randomized controlled trial will test the effectiveness of Eatable Alphabet cards, a child friendly nutrition education tool, on child weight and related behaviors in a clinical sample of 2 to 10-year-old children with overweight/obesity, referred to a pediatric weight management program.
Primary Outcome
Parents will complete pre and post intervention/usual care survey measures of vegetable consumption.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Eatable Alphabet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What the registry record for NCT05166629 still lists
NCT05166629 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT05166629 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05166629 about?
NCT05166629 is a clinical study titled "Eatable Alphabet as a Nutrition Education Tool". This pilot randomized controlled trial will test the effectiveness of Eatable Alphabet cards, a child friendly nutrition education tool, on child weight and related behaviors in a clinical sample of 2 to 10-year-old children with overweight/obesity, referred to a pediatric weight management program.
What is the current status of trial NCT05166629?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 160 participants. The study started on 2023-09-01. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT05166629?
The interventions under investigation include: Usual Care (BEHAVIORAL), Eatable Alphabet (BEHAVIORAL).
Who is sponsoring clinical trial NCT05166629?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05166629's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI